Brian Rosenberger - Net Worth and Insider Trading

Brian Rosenberger Net Worth

The estimated net worth of Brian Rosenberger is at least $324,427 dollars as of 2024-05-26. Brian Rosenberger is the VP, Commercial & Business Dev. of Zynerba Pharmaceuticals Inc and owns about 249,559 shares of Zynerba Pharmaceuticals Inc (ZYNE) stock worth over $324,427. Details can be seen in Brian Rosenberger's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Brian Rosenberger has not made any transactions after 2023-09-13 and currently still holds the listed stock(s).

Transaction Summary of Brian Rosenberger

To

Brian Rosenberger Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Brian Rosenberger owns 1 companies in total, including Zynerba Pharmaceuticals Inc (ZYNE) .

Click here to see the complete history of Brian Rosenberger’s form 4 insider trades.

Insider Ownership Summary of Brian Rosenberger

Ticker Comapny Transaction Date Type of Owner
ZYNE Zynerba Pharmaceuticals Inc 2023-09-13 VP & Commercial & Business Dev.

Brian Rosenberger Latest Holdings Summary

Brian Rosenberger currently owns a total of 1 stock. Brian Rosenberger owns 249,559 shares of Zynerba Pharmaceuticals Inc (ZYNE) as of September 13, 2023, with a value of $324,427.

Latest Holdings of Brian Rosenberger

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ZYNE Zynerba Pharmaceuticals Inc 2023-09-13 249,559 1.30 324,427

Holding Weightings of Brian Rosenberger


Brian Rosenberger Form 4 Trading Tracker

According to the SEC Form 4 filings, Brian Rosenberger has made a total of 3 transactions in Zynerba Pharmaceuticals Inc (ZYNE) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Zynerba Pharmaceuticals Inc is the sale of 6,411 shares on September 13, 2023, which brought Brian Rosenberger around $8,527.

Insider Trading History of Brian Rosenberger

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Brian Rosenberger Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Brian Rosenberger Ownership Network

Ownership Network List of Brian Rosenberger

No Data

Ownership Network Relation of Brian Rosenberger


Brian Rosenberger Owned Company Details

What does Zynerba Pharmaceuticals Inc do?

Who are the key executives at Zynerba Pharmaceuticals Inc?

Brian Rosenberger is the VP & Commercial & Business Dev. of Zynerba Pharmaceuticals Inc. Other key executives at Zynerba Pharmaceuticals Inc include Chief Financial Officer James E Fickenscher , director & Chairman & Chief Exec. Officer Armando Anido , and President Terri B Sebree .

Zynerba Pharmaceuticals Inc (ZYNE) Insider Trades Summary

Over the past 18 months, Brian Rosenberger made 2 insider transaction in Zynerba Pharmaceuticals Inc (ZYNE) with a net sale of 19,074. Other recent insider transactions involving Zynerba Pharmaceuticals Inc (ZYNE) include a net sale of 53,283 shares made by Armando Anido , a net sale of 37,062 shares made by Terri B Sebree , and a net sale of 26,767 shares made by James E Fickenscher .

In summary, during the past 3 months, insiders sold 0 shares of Zynerba Pharmaceuticals Inc (ZYNE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 139,381 shares of Zynerba Pharmaceuticals Inc (ZYNE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 139,381 shares.

Zynerba Pharmaceuticals Inc (ZYNE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Zynerba Pharmaceuticals Inc Insider Transactions

No Available Data

Brian Rosenberger Mailing Address

Above is the net worth, insider trading, and ownership report for Brian Rosenberger. You might contact Brian Rosenberger via mailing address: C/o Zynerba Pharmaceuticals, Inc., 80 West Lancaster Avenue, Suite 300, Devon Pa 19333.

Discussions on Brian Rosenberger

No discussions yet.